{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:26:38Z","timestamp":1790695598333,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.acvd.2019.06.008","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T17:46:28Z","timestamp":1567187188000},"page":"699-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study"],"prefix":"10.1016","volume":"112","author":[{"given":"Joe-Elie","family":"Salem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Bretagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Lebrun-Vignes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Waintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Gandjbakhch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Hidden-Lucet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gougis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bachelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Funck-Brentano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2019.06.008_bib0250","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2019.06.008_bib0255","doi-asserted-by":"crossref","first-page":"e0181875","DOI":"10.1371\/journal.pone.0181875","article-title":"GENomE wide analysis of sotalol-induced IKr inhibition during ventricular REPOLarization, \u201cGENEREPOL study\u201d: Lack of common variants with large effect sizes","volume":"12","author":"Salem","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.acvd.2019.06.008_bib0260","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0735-1097(94)90410-3","article-title":"Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome","volume":"23","author":"Malfatto","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.06.008_bib0265","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/01.CIR.0000048142.85076.A2","article-title":"Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome","volume":"107","author":"Takenaka","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.06.008_bib0270","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/clpt.2010.51","article-title":"Covariate analysis of QTc and T-wave morphology: new possibilities in the evaluation of drugs that affect cardiac repolarization","volume":"88","author":"Graff","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.acvd.2019.06.008_bib0275","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pharmthera.2016.07.005","article-title":"Influence of steroid hormones on ventricular repolarization","volume":"167","author":"Salem","year":"2016","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.acvd.2019.06.008_bib0280","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1001\/jama.1993.03510210076031","article-title":"Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs","volume":"270","author":"Makkar","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2019.06.008_bib0285","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jamacardio.2018.2251","article-title":"Association of oral contraceptives with drug-induced QT interval prolongation in healthy non-menopausal women","volume":"3","author":"Salem","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.acvd.2019.06.008_bib0290","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1210\/jc.2016-1877","article-title":"Complex influence of gonadotropins and sex steroid hormones on QT interval duration","volume":"101","author":"Abehsira","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.acvd.2019.06.008_bib0295","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.amjcard.2008.11.041","article-title":"Effects of testosterone on ventricular repolarization in hypogonadic men","volume":"103","author":"Charbit","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2019.06.008_bib0300","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/cvr\/cvz020","article-title":"Cardiac arrhythmia considerations of hormone cancer therapies","volume":"115","author":"Barber","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.acvd.2019.06.008_bib0305","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1210\/jc.2017-00196","article-title":"Effects of testosterone replacement on electrocardiographic parameters in men: findings from two randomized trials","volume":"102","author":"Gagliano-Juca","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.acvd.2019.06.008_bib0310","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/CIRCULATIONAHA.118.034282","article-title":"Hypogonadism as a reversible cause of torsades de pointes in men","volume":"138","author":"Salem","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.06.008_bib0315","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2125.2012.04185.x","article-title":"Trends of reporting of \u201cserious\u201d vs \u201cnon-serious\u201d adverse drug reactions over time: a study in the French PharmacoVigilance Database","volume":"74","author":"Moulis","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.acvd.2019.06.008_bib0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.acvd.2016.12.011","article-title":"Fast, accurate and easy-to-teach QT interval assessment: the triplicate concatenation method","author":"Saque","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2019.06.008_bib0325","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ijcard.2014.04.133","article-title":"New age- and sex-specific criteria for QT prolongation based on rate correction formulas that minimize bias at the upper normal limits","volume":"174","author":"Rautaharju","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2019.06.008_bib0330","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/jhg.2015.74","article-title":"Genetics of long-QT syndrome","volume":"61","author":"Nakano","year":"2016","journal-title":"J Hum Genet"},{"key":"10.1016\/j.acvd.2019.06.008_bib0335","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMcps1311794","article-title":"Clinical problem-solving. From dancing to debilitated","volume":"374","author":"Houston","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2019.06.008_bib0340","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1210\/jc.2015-3357","article-title":"Endocrine manifestations in a monocentric cohort of 64 patients with erdheim-chester disease","volume":"101","author":"Courtillot","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.acvd.2019.06.008_bib0345","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMoa1502309","article-title":"Vemurafenib in multiple nonmelanoma cancers with brAF V600 mutations","volume":"373","author":"Hyman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2019.06.008_bib0350","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2019.06.008_bib0355","first-page":"124","article-title":"Life threatening torsades de pointes due to abiraterone-induced hypokaelemia in a patient with metastatic prostate cancer","volume":"129","author":"Khan","year":"2016","journal-title":"N Z Med J"},{"key":"10.1016\/j.acvd.2019.06.008_bib0360","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/1060028014555362","article-title":"Abiraterone acetate-induced life-threatening torsade de pointes","volume":"49","author":"Rodieux","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.acvd.2019.06.008_bib0365","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1536\/ihj.18-127","article-title":"Medical castration is a rare but possible trigger of torsade de pointes and ventricular fibrillation","volume":"60","author":"Hasegawa","year":"2019","journal-title":"Int Heart J"},{"key":"10.1016\/j.acvd.2019.06.008_bib0370","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/CCM.0b013e318232db4a","article-title":"High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: results of the QT in Practice (QTIP) Study","volume":"40","author":"Pickham","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.acvd.2019.06.008_bib0375","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrcardio.2015.110","article-title":"Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms","volume":"13","author":"Frommeyer","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.acvd.2019.06.008_bib0380","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0911101","article-title":"Identification of late-onset hypogonadism in middle-aged and elderly men","volume":"363","author":"Wu","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2019.06.008_bib0385","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2019.06.008_bib0390","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pharmthera.2013.04.008","article-title":"The Lambeth Conventions (II): guidelines for the study of animal and human ventricular and supraventricular arrhythmias","volume":"139","author":"Curtis","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.acvd.2019.06.008_bib0395","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11102-008-0130-6","article-title":"Chapter 1: pathophysiology of hypopituitarism in the setting of brain injury","volume":"15","author":"Dusick","year":"2008","journal-title":"Pituitary"},{"key":"10.1016\/j.acvd.2019.06.008_bib0400","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.acvd.2019.06.008_bib0405","first-page":"3217","article-title":"Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness","volume":"86","author":"van den Berghe","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.acvd.2019.06.008_bib0410","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1089\/neu.2009.1092","article-title":"Acute gonadotroph and somatotroph hormonal suppression after traumatic brain injury","volume":"27","author":"Wagner","year":"2010","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.acvd.2019.06.008_bib0415","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/beem.2001.0165","article-title":"Altered gonadal steroidogenesis in critical illness: is treatment with anabolic steroids indicated?","volume":"15","author":"Spratt","year":"2001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.acvd.2019.06.008_bib0420","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2013-2052","article-title":"Late-onset hypogonadism and mortality in aging men","volume":"99","author":"Pye","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.acvd.2019.06.008_bib0425","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1210\/jc.2015-1571","article-title":"Development of and recovery from secondary hypogonadism in aging men: prospective results from the EMAS","volume":"100","author":"Rastrelli","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.acvd.2019.06.008_bib0430","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.119.040162","article-title":"Androgenic effects on ventricular repolarization: a translational study from the international pharmacovigilance database to iPSC-Cardiomyocytes","author":"Salem","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.06.008_bib0435","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11102-008-0130-6","article-title":"Pathophysiology of hypopituitarism in the setting of brain injury","volume":"15","author":"Dusick","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.acvd.2019.06.008_bib0440","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2015.12.063","article-title":"Predicting the unpredictable: drug-induced QT prolongation and torsades de pointes","volume":"67","author":"Schwartz","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.06.008_bib0445","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pharmthera.2018.04.009","article-title":"Anticancer drug-induced cardiac rhythm disorders: current knowledge and basic underlying mechanisms","volume":"189","author":"Alexandre","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.acvd.2019.06.008_bib0450","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/CIRCULATIONAHA.109.192695","article-title":"Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology","volume":"121","author":"Levine","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.06.008_bib0455","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.juro.2010.08.012","article-title":"Cardiovascular safety of degarelix: results from a 12-month, comparative, randomized, open label, parallel group phase III trial in patients with prostate cancer","volume":"184","author":"Smith","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.acvd.2019.06.008_bib0460","doi-asserted-by":"crossref","first-page":"e3845","DOI":"10.1097\/MD.0000000000003845","article-title":"A meta-analysis and systematic review of randomized controlled trials with degarelix versus gonadotropin-releasing hormone agonists for advanced prostate cancer","volume":"95","author":"Sciarra","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.acvd.2019.06.008_bib0465","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1464-410X.2008.08183.x","article-title":"The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer","volume":"102","author":"Klotz","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.acvd.2019.06.008_bib0470","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2004.22.90140.4578","article-title":"The effect of hormonal therapy for prostate cancer on the electrocardiographic QT interval: phase 3 results following treatment with leuprolide and goserelin alone or with bicalutamide, and the GnRH antagonist abarelix","volume":"22","author":"Garnick","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acvd.2019.06.008_bib0475","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJM199401133300208","article-title":"Finasteride","volume":"330","author":"Rittmaster","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2019.06.008_bib0480","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/CMAR.S8841","article-title":"Evaluation of degarelix in the management of prostate cancer","volume":"2","author":"Van Poppel","year":"2010","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.acvd.2019.06.008_bib0485","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJMoa1704174","article-title":"Abiraterone plus prednisone in metastatic castration-sensitive prostate cancer","volume":"377","author":"Fizazi","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2019.06.008_bib0490","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.therap.2017.05.003","article-title":"interval due to antiandrogenic therapy, majorated by psychotropic drugs: about one case","volume":"72","author":"Heitzmann","year":"2017","journal-title":"Therapie"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213619301408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213619301408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:45:34Z","timestamp":1761745534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213619301408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1875213619301408"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2019.06.008","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2019.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}